The 
INTRODUCTION
Cisplatin is a broadly used anticancer agent (1). However, its usage has been limited by kidney toxicity and nephrotoxicity. In the past several years, numerous studies were focused on the mechanism of the interaction between cisplatin and cells, with particular attention to the interaction with DNA (1, 2). Recently, the research has been extended to membrane lipid, membranae protein (3) and cytoskeleton (4). It is believed that the drugmembrane interaction plays a key role in the toxicity of antitumor agents. A "multi-targets" mode has been suggested to describe the cellular response as a whole with the biomembrane as the initial target (3). Any exogenous compounds, including drug molecules must penetrate the membrane before arriving at other intracellular targets. The interaction of drug molecules with membrane lipid and membrane protein will influence membrane permeability. This process is thought to be the basis of toxicity and activity of drugs. In addition to cis-DCDP, several other analog compounds such as carboplatin (CBDCA) have been used clinically (5).
In the present work, the effects of cis-DCDP and its analogues on membrane penetration are reported. Electron spin resonance spectroscopy (6) has been used to investigate the reaction kinetics between ascorbate and the paramagnetic group of a spin label intercalated in membrane. The effects of various Pt(II) complexes, such as cisdichlorodiammineplatinum (cis-DCDP) (I), cisdibromodiammineplatinum (cis-DBDP) (II), cisdiiododiammineplatinum (cis-DIDP) (III), transdichlorodiammineplatinum (trans-DCDP) (IV) and cisdiamminediaquoplatinum (cis-DADP)(V) on (Fig 1) .
The reduction rate of the spin label was quantified by comparing the signal amplitude on the low-field region of the ESR spectrum, which decreases as the measurement time increases. The half-time T, when the amplitude of ESR signal reduced to 50 % of the original value, gives the rate of the solutes across the membrane, and the Tou and Tin represent the permeability of TEMPO molecule and ascorbate ion across the membrane bilayer, respectively. Also, Tin was used for the stearic acid spin label studies.
The permeation rate of ascorbate into the membrane is temperature dependent (6).
Samples with TEMPO spin label were measured at 0C, since at this temperature, ascorbate ion can not penetrate into biomembrane. However, with the stearic acid spin-labeled system, the experiments were carried out at room temperature at which the ascorbate ion can enter the membrane bilayer.
The effects of Pt(II) complexes on lipid organization of membrane were studied by measuring the order parameter of spin label 5DS. The order parameter S which indicates the fluidity of biomembrane, was calculated following ref. (9). RESULTS 1. The effects of Pt(II) complexes on the permeability of TEMPO spin labels from the lipid bilayer to the outside of the membranes.
Three-dimensional ESR spectra of TEMPO spin label in the human erythrocyte membrane at different times are shown in Fig. 1 . The ESR signal amplitude is reduced by adding ascorbate ion at 0C. A transport process of solute from extracellular space includes at least two fundamental steps" first is the entry from the extracellular aqueous phase into the lipid medium (across membrane surface), and the second step is the diffusion along the acyl chains of phospholipid molecules (diffusion process). A small molecule, such as the spin label TEMPO, is likely to penetrate through the membrane according to a simple passive diffusion following a concentration gradient. However, the transport of ascorbate ions is perhaps due to a facilitated diffusion which has been mediated by a special ion pathway in the membrane.
The experimental results show that the permeability of human erythrocyte membrane increases in the presence of Pt(II) complexes for both TEMPO molecule and ascorbate ion. When Pt(II) complex attack membranes the electrostatic interactions could take place at the membrane surface, and the positively charged hydrolytic products of these Pt(II) complexes tend to alter the charge barrier of the membrane surface. Since the hydrolysis of Pt(II) complex is a slow and reversible process, the system is in a non-equilibrium during the experiment. Both hydrolytic and non-hydrolytic Pt(II) complexes exist outside the membrane and change the surface feature of the biomembrane in different manners, which then affect the permeability of differem solutes (11).
The substitution ability of a ligand (or a leaving group) of a Pt(II) complex in an aqueous system was summarized (12) in the following order: HzO >C1-> Br-> I-.
However, the hydrolysis of dichlorodiammineplatinum (II) 
